Korify Capital AG
Korify Capital invests in late stage/pre IPO venture opportunities and makes opportunity-driven investments in smaller companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Korify Capital AG Information
Geographic Data
Address: Lange Gasse 15
City: Basel
State: basel-country
Zip: 4052
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
The firm has a strong focus on the biotech sector in the United States, Europe and Israel, but also selectively invests in fintech and blockchain opportunities.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2022 | FORME | Series A | 69.9M |
| 9/2021 | Olsam Group | Series A | 0 |
| 1/2022 | Storypod | Seed Round | 4M |
| 1/2022 | Storypod | Seed Round | 0 |
| 3/2021 | nextmarkets | Series B | 0 |
| 8/2021 | Refoxy Pharma | Seed Round | - |
| 11/2022 | Bionomics | Post-IPO Equity | 5M |
| 3/2021 | ATAI Life Sciences | Series D | 0 |
| 11/2020 | ATAI Life Sciences | Series C | 0 |
| 12/2020 | Rejuveron Life Sciences | Series A | - |
| 10/2021 | Cambrian Biopharma | Series C | 0 |
| 10/2022 | Alto Neuroscience | Series B | 35M |
| 8/2021 | Wonder brands | Seed Round | 0 |
| 7/2021 | Samsara Therapeutics | Series A | 0 |
| 5/2021 | Bullish Global | Venture Round | 300M |
| 5/2021 | Alto Neuroscience | Series A | 0 |
| 2/2021 | Cambrian Biopharma | Series B | 0 |
| 1/2021 | Sensei Biotherapeutics | Series B | 0 |
| 4/2022 | AMZSCALE | Series A | - |
| 5/2021 | LEAF4Life | Series B | - |
| 9/2022 | Gameto | Venture Round | 17M |
| 3/2021 | nextmarkets | Series B | - |
| 8/2021 | Wonder brands | Seed Round | 0 |
| 7/2021 | Samsara Therapeutics | Series A | 0 |
| 5/2021 | Bullish Global | Venture Round | 0 |
| 5/2021 | Alto Neuroscience | Series A | 0 |
| 3/2021 | nextmarkets | Series B | - |
| 3/2021 | ATAI Life Sciences | Series D | 0 |
| 2/2021 | Cambrian Biopharma | Series B | 0 |
| 1/2021 | Sensei Biotherapeutics | Series B | 0 |
| 12/2020 | Rejuveron Life Sciences | Series A | - |
| 11/2020 | ATAI Life Sciences | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
